Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BANNER CORPBANR · Entity 4398 | Director | November 18, 2016 | November 22, 2016 |
| CLOROX CO /DE/CLX · Entity 3474 | Director | December 31, 2025 | January 05, 2026 |
| LEVI STRAUSS & COLEVI · Entity 3651 | Director | August 08, 2025 | August 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BANNER CORP
Report date November 18, 2016 · Filed November 22, 2016
Jointly reported with FRIEDMAN FLEISCHER & LOWE CAPITAL PARTNERS III LP, FRIEDMAN FLEISCHER & LOWE PARALLEL FUND III LP, FFL Individual Partners III, L.P., FFL EXECUTIVE PARTNERS III LP, Friedman Fleischer & Lowe GP III, L.P., Friedman Fleischer & Lowe GP III, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | IndirectSee footnotes | 571,800 |
Reported balance
After 2016-11-18 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2016-11-18 · Sale · Disposed 422,693 · Balance 571,800 F2: Held directly by Friedman Fleischer & Lowe Capital Partners III, L.P. F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. |
| Common stock, $0.01 par value per shareSEC Table I · non-derivative | IndirectSee footnotes | 378,924 |
Reported balance
After 2016-11-18 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2016-11-18 · Sale · Disposed 280,111 · Balance 378,924 F3: Held directly by Friedman Fleischer & Lowe Parallel Fund III, L.P. F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. |
| Common stock, $0.01 par value per shareSEC Table I · non-derivative | IndirectSee footnotes | 12,113 |
Reported balance
After 2016-11-18 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2016-11-18 · Sale · Disposed 8,954 · Balance 12,113 F4: Held directly by FFL Individual Partners III, L.P. F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. |
| Common stock, $0.01 par value per shareSEC Table I · non-derivative | IndirectSee footnotes | 11,151 |
Reported balance
After 2016-11-18 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2016-11-18 · Sale · Disposed 8,242 · Balance 11,151 F5: Held directly by FFL Executive Partners, L.P. F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1. F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer. |
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | Direct | 697 |
Reported balance
Holding disclosure · report date 2016-11-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 697 F1: Represents award of restricted stock pursuant to 2014 Omnibus Incentive Plan; shares fully vest on April 25, 2017. These shares are subject to forfeiture and to limits on transferability until they vest. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents award of restricted stock pursuant to 2014 Omnibus Incentive Plan; shares fully vest on April 25, 2017. These shares are subject to forfeiture and to limits on transferability until they vest.
F2: Held directly by Friedman Fleischer & Lowe Capital Partners III, L.P.
F3: Held directly by Friedman Fleischer & Lowe Parallel Fund III, L.P.
F4: Held directly by FFL Individual Partners III, L.P.
F5: Held directly by FFL Executive Partners, L.P.
F6: Each Reporting Person expressly disclaims beneficial ownership of the shares except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1.
F7: Solely for purposes of Section 16 of the Securities Exchange Act of 1934, each of Friedman Fleischer & Lowe Capital Partners III, L.P., Friedman Fleischer & Lowe Parallel Fund III, L.P., FFL Individual Partners III, L.P., FFL Executive Partners III, L.P., Friedman Fleischer & Lowe GP III, L.P. and Friedman Fleischer & Lowe GP III, LLC (the "FFL Reporting Persons"), may be deemed to be directors-by-deputization by virtue of their right to designate a member of the board of directors of the Issuer. The FFL Reporting Persons designated Spencer C. Fleischer as a member of the board of directors of the Issuer, effective October 1, 2015 pursuant to that certain Investment Letter Agreement, dated as of November 5, 2014, by and between the FFL Funds (as defined in Exhibit 99.1) and the Issuer.
CLOROX CO /DE/
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,018.8638 |
Reported balance
After 2025-11-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-06 · Grant · Acquired 219.3396 · Balance 19,018.8638 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 20,238.021 |
Reported balance
After 2025-12-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-31 · Grant · Acquired 1,219.1572 · Balance 20,238.021 F1: 1-for-1 F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 20,383.2827 |
Reported balance
After 2025-12-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-12-31 · Grant · Acquired 145.2617 · Balance 20,383.2827 F1: 1-for-1 F5: Receipt of Deferred Stock Units in lieu of portion of quarterly director's fees. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
F5: Receipt of Deferred Stock Units in lieu of portion of quarterly director's fees.
LEVI STRAUSS & CO
Report date August 08, 2025 · Filed August 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 64,500 |
Reported balance
After 2025-08-08 transaction · row 1
1 source rowRow 1 · 2025-08-08 · Grant · Acquired 213 · Balance 64,500 F1: Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs. |
| Class B Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 116,515 |
Reported balance
After 2025-08-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-08-08 · Grant · Acquired 187 · Balance 116,515 F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs.
F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F3: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2025 Filed Jan 5, 2026 21:44 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 145.2617 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000174 · doc4.xml · derivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,383.2827 Underlying: Common Stock · 145.2617 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F5 · kind: Receipt of Deferred Stock Units in lieu of portion of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:44 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,219.1572 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000174 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,238.021 Underlying: Common Stock · 1,219.1572 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 06, 2025 Filed Jan 5, 2026 21:44 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 219.3396 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000174 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,018.8638 Underlying: Common Stock · 219.3396 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:17 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 212.8954 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008289 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,799.5242 Underlying: Common Stock · 212.8954 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 29, 2025 Filed Oct 2, 2025 20:17 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 192.9623 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-008289 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,586.6288 Underlying: Common Stock · 192.9623 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:57 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 187 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-25-011153 · fleischer-form4_081225.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,515 Underlying: Class A Common Stock · 187 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:57 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 213 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-25-011153 · fleischer-form4_081225.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,500 F1 · shares: Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:28 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 241.5029 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006369 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,393.6665 Underlying: Common Stock · 241.5029 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 09, 2025 Filed May 13, 2025 01:59 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-25-005909 · fleischer-form4_051225.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,328 Underlying: Class A Common Stock · 200 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| May 09, 2025 Filed May 13, 2025 01:59 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 229 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-25-005909 · fleischer-form4_051225.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,287 F1 · shares: Represents dividend equivalent rights (DERs), each of which represent a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs. Read SEC document |
| May 09, 2025 Filed Jul 2, 2025 20:28 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 162.8595 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-006369 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,152.1635 Underlying: Common Stock · 162.8595 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:21 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 11,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-25-004781 · fleischer_form4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,058 F1 · shares: Represents the acquisition of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The RSUs will vest in full the earlier of the day before the next annual stockholder meeting or the first anniversary of the grant date. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:16 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 212.2241 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003870 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,989.304 Underlying: Common Stock · 212.2241 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:49 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 190 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001839882-25-013577 · fleischer_form4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,128 Underlying: Class A Common Stock · 190 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:49 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 134 | $0.00 | $0.00 |
DisclosureSEC source: 0001839882-25-013577 · fleischer_form4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,368 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. The underlying shares of Class A Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. Read SEC document |
| February 14, 2025 Filed Apr 2, 2025 20:16 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 145.4207 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003870 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,777.08 Underlying: Common Stock · 145.4207 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 192.4143 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000199 · doc4.xml · derivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,631.6593 Underlying: Common Stock · 192.4143 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F5 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,000.7162 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000199 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,439.245 Underlying: Common Stock · 1,000.7162 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:45 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 203 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001839882-24-039783 · fleischer-form4_111424.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,938 Underlying: Class A Common Stock · 203 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:45 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 143 | $0.00 | $0.00 |
DisclosureSEC source: 0001839882-24-039783 · fleischer-form4_111424.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,234 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. With respect to 83 of the DERs, the DERs are fully vested. With respect to 60 of the DERs, the DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. The underlying shares of Class A Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. Read SEC document |
| November 07, 2024 Filed Jan 3, 2025 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 122.2941 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000199 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,438.5288 Underlying: Common Stock · 122.2941 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 22:35 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 191.8237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009056 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,316.2347 Underlying: Common Stock · 191.8237 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 30, 2024 Filed Oct 2, 2024 22:35 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 123.3109 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009056 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,124.411 Underlying: Common Stock · 123.3109 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 20, 2024 Filed Aug 23, 2024 00:48 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 178 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-24-010540 · ownership.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,735 Underlying: Class A Common Stock · 178 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| August 20, 2024 Filed Aug 23, 2024 00:48 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 124 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-24-010540 · ownership.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,091 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. With respect to 72 of the DERs, the DERs are fully vested. With respect to 52 of the DERs, the DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. The underlying shares of Class A Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:37 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 228.9881 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-007230 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,001.1001 Underlying: Common Stock · 228.9881 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 23, 2024 Filed May 28, 2024 21:41 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 143 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-24-006717 · ownership.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,557 Underlying: Class A Common Stock · 143 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| May 23, 2024 Filed May 28, 2024 21:41 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-24-006717 · ownership.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,967 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. With respect to 58 of the DERs, the DERs are fully vested. With respect to 42 of the DERs, the DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. The underlying shares of Class A Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. Read SEC document |
| May 10, 2024 Filed Jul 2, 2024 20:37 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 130.9342 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-007230 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,772.1121 Underlying: Common Stock · 130.9342 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| April 24, 2024 Filed Apr 27, 2024 00:56 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 7,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-24-005253 · ownership.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,867 F1 · shares: Represents the acquisition of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The RSUs will vest in full the earlier of the day before the next annual stockholder meeting or the first anniversary of the grant date. F2 · balance_after: Includes 18,228 RSUs that may be settled in shares of Class A Common Stock, including RSUs previously issued in the form of dividend equivalent rights (DERs). 7,642 of the RSUs vest in full the earlier of the day before the next annual stockholder meeting or the first anniversary of the date of grant and 10,586 of the outstanding RSUs have vested. All such RSUs are subject to a deferral delivery feature at the election of the reporting person. Each RSU represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 22:32 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 204.1016 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-004836 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,641.1779 Underlying: Common Stock · 204.1016 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 23:27 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 169 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-24-002765 · fleischer_form4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,414 Underlying: Class A Common Stock · 169 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 23:27 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-24-002765 · fleischer_form4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,225 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. The underlying shares of Class A Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. Read SEC document |
| February 09, 2024 Filed Apr 2, 2024 22:32 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 119.9773 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-004836 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,437.0763 Underlying: Common Stock · 119.9773 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:46 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 219.1598 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000255 · doc4.xml · derivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,317.099 Underlying: Common Stock · 219.1598 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F5 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:46 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,117.3538 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000255 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,097.9392 Underlying: Common Stock · 1,117.3538 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 09, 2023 Filed Nov 14, 2023 01:45 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 214 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001999371-23-000152 · ownership.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,245 Underlying: Class A Common Stock · 214 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| November 09, 2023 Filed Nov 14, 2023 01:45 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 87 | $0.00 | $0.00 |
DisclosureSEC source: 0001999371-23-000152 · ownership.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,156 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. The underlying shares of Class A Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. Read SEC document |
| November 09, 2023 Filed Jan 3, 2024 21:46 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 125.6494 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000255 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,980.5854 Underlying: Common Stock · 125.6494 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 234.6254 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009227 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,854.936 Underlying: Common Stock · 234.6254 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 25, 2023 Filed Oct 3, 2023 20:19 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 104.9533 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-009227 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,620.3107 Underlying: Common Stock · 104.9533 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 22:34 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 216 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-046790 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,031 Underlying: Class A Common Stock · 216 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 22:34 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 88 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-046790 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,069 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. The underlying shares of Class A Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:17 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 193.3476 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-007233 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,515.3574 Underlying: Common Stock · 193.3476 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 18, 2023 Filed May 23, 2023 00:59 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass B Common Stock · Derivative | 224 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031619 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,815 Underlying: Class B Common Stock · 224 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · shares: Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Read SEC document |
| May 18, 2023 Filed May 23, 2023 00:59 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 129 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031619 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,981 F1 · shares: Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. With respect to 38 of the DERs, the DERs shall vest in a series of three equal installments on the dates that are 13, 24 and 36 months following the date of grant. With respect to 91 of the DERs, the DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant. Certain of the shares of the underlying Class A Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature. Read SEC document |
| May 12, 2023 Filed Jul 5, 2023 20:17 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 92.3021 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-007233 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,322.0098 Underlying: Common Stock · 92.3021 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 22:41 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 10,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025263 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,852 F1 · shares: Represents the acquisition of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The RSUs will vest in full the earlier of the day before the next annual stockholder meeting or the first anniversary of the grant date. F2 · balance_after: Includes 14,577 RSUs that may be settled in shares of Class A Common Stock, including RSUs previously issued in the form of dividend equivalent rights (DERs). Each RSU represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. 4,326 of the RSUs vest in a series of three equal installments on the dates that are 13, 24 and 36 months following the date of grant and 10,251 of the RSUs vest in full the earlier of the day before the next annual stockholder meeting or the first anniversary of the date of grant. Certain of such RSUs are subject to a deferral delivery feature. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:16 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 194.3251 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004530 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,229.7077 Underlying: Common Stock · 194.3251 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 02:55 UTC | LEVI STRAUSS & CO LEVI · Entity 3651 | GrantClass A Common Stock | 81 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013525 · doc4.xml · nonDerivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,592 F2 · shares: Represents RSUs for Class A common stock constituting DERs issued pursuant to existing Class A common stock RSUs held by the holder (the "Underlying Class A RSUs"). DERs are issued with regard to the Underlying Class A RSUs, which bear dividend equivalent rights, when and as dividends were paid on the Issuer's Class A common stock. Each DER represents a contingent right to receive one share of Class A common stock. With respect to 28 of the DERs, the DERs vest in a series of three equal installments on the dates that are 13, 24 and 36 months following the date of grant of the corresponding Underlying Class A RSUs. With respect to 53 of the DERs, the DERs vest as to 100% of the shares on the earlier of the date before the next annual meeting of shareholders or the first anniversary of the date of grant of the corresponding Underlying Class A RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.